Holen Sie sich die Stockscreener-App
0.3643
1.98%
0.000100
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
Harvard Bioscience’s Bertrand Loy to Step Down - TipRanks
Benchmark reiterates Harvard Bioscience stock with $4.50 target By Investing.com - Investing.com India
Harvard Bioscience’s (HBIO) Sector Weight Rating Reiterated at KeyCorp - Defense World
Harvard Bioscience (HBIO) Announces CFO Transition - GuruFocus
Harvard Bioscience Announces CFO Transition | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Sees CFO Transition with Interim Appoi - GuruFocus
Lacklustre Performance Is Driving Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 49% Price Drop - simplywall.st
Harvard Bioscience Appoints Mark Frost as Interim CFO - citybiz
Harvard Bioscience appoints interim CFO amid market challenges By Investing.com - Investing.com Canada
Harvard Bioscience CFO Jennifer Cote Resigns - marketscreener.com
Harvard Bioscience CFO Resignation and Interim Appointment - TipRanks
Harvard Bioscience appoints interim CFO amid market challenges - Investing.com
Harvard Bioscience Announces CFO Transition - The Manila Times
KeyBanc cuts Harvard Bioscience stock rating on financing risk By Investing.com - Investing.com Canada
Estimating The Fair Value Of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Yahoo Finance
KeyBanc Downgrades Harvard Bioscience to Sector Weight From Overweight, Removes $3 Price Target - marketscreener.com
KeyBanc cuts Harvard Bioscience stock rating on financing risk - Investing.com
Harvard Bioscience Slides As Insider Purchases Lose Another US$76k - simplywall.st
Harvard Bioscience (NASDAQ:HBIO) Price Target Cut to $4.50 by Analysts at Benchmark - Defense World
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges - Investing.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Harvard Bioscience Reports 2024 Financial Results - TipRanks
Harvard Bioscience Navigates Growth Amid Challenges - TipRanks
Harvard Bioscience secures waiver for credit covenant By Investing.com - Investing.com Australia
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 - GlobeNewswire
Harvard Bioscience CEO to Host Fireside Chats at Roth and KeyBanc Healthcare Forums - StockTitan
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire
Earnings call transcript: Harvard Bioscience Q4 2024 beats expectations but faces market challenges - Investing.com
Harvard Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Harvard Bioscience slumps after weak revenue forecast - TradingView
HARVARD BIOSCIENCE Earnings Results: $HBIO Reports Quarterly Earnings - Nasdaq
Harvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last year - TipRanks
Harvard Bioscience earnings beat, revenue topped estimates By Investing.com - Investing.com UK
Harvard Bioscience Achieves Profit Turnaround Despite Revenue Challenges in Latest Quarter - StockTitan
Harvard Bioscience IncQ4 2024 Revenues $24.6 Million -March 12, 2025 at 07:04 am EDT - Marketscreener.com
Harvard Bioscience Q4 and Full-Year 2024 Financial Results - TradingView
Harvard Bioscience secures waiver for credit covenant - Investing.com
Harvard BioscienceExploring Alternative Capital Sources For Refinancing Outstanding Indebtedness By June 30 - Marketscreener.com
Costco Price Plunge Equals Opportunity for Investors - The Globe and Mail
Harvard Bioscience (HBIO) Expected to Announce Earnings on Wednesday - The AM Reporter
Harvard Bioscience, Inc. to Host Earnings Call - ACCESS Newswire
HBIO stock touches 52-week low at $0.86 amid market challenges - Investing.com Australia
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):